Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

75.0%

3 terminated/withdrawn out of 4 trials

Success Rate

25.0%

-61.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04120337Not ApplicableCompleted

Safe Access: Trial With RemovAid Device

Role: lead

NCT03912649Not ApplicableTerminated

Investigation to Evaluate Performance and Safety of RemovAid ™ in Removal of Contraceptive Implants

Role: lead

NCT03356119Not ApplicableTerminated

Pilot Removal of Palpable Subdermal Contraceptive Rod Implants

Role: lead

NCT02986971Not ApplicableTerminated

Removal of Palpable Subdermal Contraceptive Rod Implants.

Role: lead

All 4 trials loaded